Connection

Quique Bassat to Quinolines

Back to Details
This is a "connection" page, showing publications Quique Bassat has written about Quinolines.
Quique Bassat
Connection Strength
0.792
Quinolines
  1. Reappraising the cardiosafety of dihydroartemisinin-piperaquine. Lancet Infect Dis. 2018 08; 18(8):824-826.
    View in: PubMed
    Score: 0.529
  2. Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration. Antimicrob Agents Chemother. 2018 12; 62(12).
    View in: PubMed
    Score: 0.137
  3. A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria. BMC Med. 2017 10 09; 15(1):181.
    View in: PubMed
    Score: 0.126
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.